首页> 外国专利> NON-PRESCRIPTION MOTION SICKNESS MEDICATION CONTAINING AN ANALGESIC, AN H2 BLOCKER, AND AT LEAST ONE ANTACID

NON-PRESCRIPTION MOTION SICKNESS MEDICATION CONTAINING AN ANALGESIC, AN H2 BLOCKER, AND AT LEAST ONE ANTACID

机译:包含止痛药,H2受体阻滞剂和至少一种抗酸药的非矫正运动病药物

摘要

The present invention provides a compounded non-prescription medication for the treatment of motion sickness. The medication comprises: at least one analgesic selected from the group consisting of acetaminophen, ibuprofen, naproxen and salicylates; at least one histamine H2-receptor antagonist selected from the group consisting of nizatidine, famotidine, cimetidine, ranitidine. famotidine; and at least one antacid selected from the group consisting of calcium carbonate, sodium bicarbonate, magnesium hydroxide, aluminum hydroxide, and bismuth subsalicylate. The medication may optionally comprise at least one additional ingredient selected from the group consisting of spearmint extract and ginger extract. The formulations are consistent in their effectiveness and devoid of the side effects of drowsiness and dry mouth. A presently preferred embodiment of the medication comprises primarily of ibuprofen, famotidine, calcium carbonate, magnesium hydroxide, spearmint extract and ginger extract.
机译:本发明提供了用于治疗晕动病的复合非处方药。该药物包括:至少一种选自对乙酰氨基酚,布洛芬,萘普生和水杨酸盐的镇痛药;至少一种选自尼扎替丁,法莫替丁,西咪替丁,雷尼替丁的组胺H 2 -受体拮抗剂。法莫替丁至少一种抗酸剂选自碳酸钙,碳酸氢钠,氢氧化镁,氢氧化铝和水杨酸铋。药物可任选地包含选自留兰香提取物和生姜提取物的至少一种其他成分。该制剂的效力是一致的,并且没有嗜睡和口干的副作用。药物的当前优选实施方案主要包括布洛芬,法莫替丁,碳酸钙,氢氧化镁,留兰香提取物和生姜提取物。

著录项

  • 公开/公告号US2020113856A1

    专利类型

  • 公开/公告日2020-04-16

    原文格式PDF

  • 申请/专利权人 SPENCER B. JONES;

    申请/专利号US201816162362

  • 发明设计人 SPENCER B. JONES;

    申请日2018-10-16

  • 分类号A61K31/192;A61K31/167;A61K31/616;A61P1/08;

  • 国家 US

  • 入库时间 2022-08-21 11:25:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号